Mutz Christopher 4
4 · ANI PHARMACEUTICALS INC · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Mutz Christopher
HEAD OF RARE DISEASE
Transactions
- Tax Payment
Common Stock
2025-02-28$61.89/sh−1,275$78,910→ 114,191 total
Footnotes (1)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported.